Vanguard Amends Eli Lilly Stake, Remains Key Passive Investor

TL;DR

**Vanguard still owns a big chunk of Eli Lilly, signaling continued institutional confidence.**

AI Summary

The Vanguard Group, a major investment firm, filed an amendment to its Schedule 13G on February 13, 2024, indicating its ownership of Eli Lilly & Co. common stock as of December 29, 2023. This filing, an amendment number 8, shows that Vanguard continues to be a significant passive investor in Eli Lilly, holding a substantial stake. For investors, this means a large, stable institutional holder like Vanguard remains committed to Eli Lilly, which can signal confidence in the company's long-term prospects.

Why It Matters

This filing confirms Vanguard's continued significant, passive ownership in Eli Lilly, which can provide a sense of stability and institutional confidence for current and prospective shareholders.

Risk Assessment

Risk Level: low — This filing is routine for large institutional investors and indicates no immediate change in Vanguard's passive investment strategy for Eli Lilly.

Analyst Insight

Investors should note that a major institutional investor like Vanguard continues to hold a significant, passive stake in Eli Lilly, which can be a sign of long-term stability, but this filing itself doesn't suggest any immediate buying or selling action.

Key Players & Entities

• The Vanguard Group (company) — reporting person and major institutional investor
• Eli Lilly & Co. (company) — subject company whose securities are being reported
• December 29, 2023 (date) — date of event requiring the filing
• February 13, 2024 (date) — date the SC 13G/A was filed
• Pennsylvania (company) — place of organization for The Vanguard Group

Forward-Looking Statements

• Vanguard will maintain its passive investment strategy in Eli Lilly for the foreseeable future. (The Vanguard Group) — high confidence, target: 2025-12-31
• Eli Lilly's stock will continue to be viewed favorably by large institutional investors due to its strong market position. (Eli Lilly & Co.) — medium confidence, target: 2024-12-31

FAQ

Filing Documents

• tv0827-elilillyco.htm (SC 13G/A) — 11KB
• 0001104659-24-020827.txt ( ) — 13KB

(a) - Name of Issuer

Item 1(a) - Name of Issuer: Eli Lilly & Co

(b) - Address of Issuer's Principal Executive Offices

Item 1(b) - Address of Issuer's Principal Executive Offices: Lilly Corporate Center Indianapolis, IN 46285

(a) - Name of Person Filing

Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930

(b) – Address of Principal Business Office or, if none, residence

Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355

(c) – Citizenship

Item 2(c) – Citizenship: Pennsylvania

(d) - Title of Class of Securities

Item 2(d) - Title of Class of Securities: Common Stock

(e) - CUSIP Number

Item 2(e) - CUSIP Number 532457108

- Type of Filing

Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).

- Ownership

Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.

- Ownership of Five Percent or Less of a Class

Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following

- Ownership of More Than Five Percent on Behalf of Another Person

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable

- Identification and Classification of Members of Group

Item 8 - Identification and Classification of Members of Group: Not applicable

- Notice of Dissolution of Group

Item 9 - Notice of Dissolution of Group: Not applicable

- Certification

Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration

View Full Filing

View this SC 13G/A filing on SEC EDGAR